Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Needling technique with topical Latanoprost in treatment of hypopigmented burn scars
IRCT20111123008177N18Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of latanoprost in hypopigmented scar and burn scar, sponsored by Iran University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
latanoprost
03
Conditions
hypopigmented scarburn scar
Beyond the preview
Go deeper on IRCT20111123008177N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111123008177N18.